Thomas Bohnacker

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• University of Basel24.2%
• PIQUR Therapeutics (Switzerland)8.5%
• AstraZeneca (Sweden)8%
• Institute of Oncology Research7.1%
• University of Victoria6.6%
• Sichuan University5.9%
• Other39.7%

Fields

• Biochemistry, Genetics and Molecular Biology64%
• Medicine20.6%
• Chemistry4.7%
• Pharmacology, Toxicology and Pharmaceutics4.7%
• Immunology and Microbiology2.8%
• Computer Science1.6%
• Other1.6%

Topics

• PI3K/AKT/mTOR signaling in cancer36.6%
• Chronic Lymphocytic Leukemia Research9.9%
• Protein Kinase Regulation and GTPase Signaling6.9%
• Cancer Mechanisms and Therapy6.6%
• Synthesis and biological activity4.6%
• Protein Degradation and Inhibitors4.3%
• Other31%